Sleep Management And Recovery After Traumatic Brain Injury in Kids: Pilot Intervention of Melatonin

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-02

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sleep wake disturbances compound recovery in over half of pediatric traumatic brain injury survivors, leading to impaired quality of life, and few effective interventions exist to treat this important morbidity. Therefore, this study will conduct a randomized controlled trial evaluating a melatonin intervention started during hospitalization and continued after discharge compared to placebo. The trial will investigate if this intervention is feasible, acceptable, and effective at reducing sleep wake disturbances as measured on the Sleep Disturbances Scale for Children 1-month after hospital discharge.

Participants will be randomly assigned to receive the intervention (melatonin) or to the control group (placebo) with a goal of equal numbers of participants in each group and all will receive sleep education. Participants will be followed closely after consent and outcomes will be assessed at hospital discharge, and 1-month. Outcomes will focus on feasibility (ability to recruit patients into the trial) and acceptability (patient safety and satisfaction), but will also assess the effectiveness of the intervention to reduce sleep disturbances after discharge. The investigators will assess sleep using questionnaires and actigraphy (watch-like activity monitors). Exploratory outcomes will include global health outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Concussion and Melatonin

NCT04731974

Concussion, Mild Concussion, Brain Pediatric ALL

RECRUITING PHASE2

Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort

NCT01700959

Cancer Malignancies

COMPLETED PHASE3

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

NCT03779243

Sleep Disturbance Trauma

COMPLETED NA

Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities

NCT01161108

Epilepsy Insomnia Developmental Disability

COMPLETED PHASE3

Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation

NCT01598259

Burns

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury Critical Illness Sleep

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Melatonin

(melatonin doses of 3mg or 5mg based on patient size given nightly 1 hour prior to bedtime every night for 30 days)

Group Type EXPERIMENTAL

melatonin

Intervention Type DRUG

melatonin supplementation

Placebo

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type OTHER

microcrystalline cellulose filled capsule

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

melatonin

melatonin supplementation

Intervention Type DRUG

placebo

microcrystalline cellulose filled capsule

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children age ≥6 years and \<19 years
* Traumatic brain injury defined as disruption of the normal function of the brain resulting from blunt force injury with a severity defined as mild complicated, moderate, or severe by the Glasgow Coma Scale with the presence of intracranial injury on imaging
* Admission to Oregon Health \& Science University Hospitals
* Deemed likely to survive hospitalization by clinical care team
* Able to tolerate enteral medications within 72 hours of admission
* Child participant resides with parent or legal guardian

Exclusion:

* Lack stable means of communication with study team (phone, email, mailing address)
* Abusive trauma suspected or confirmed
* Dialysis
* Extracorporeal support (e.g. ECMO)
* Significant liver injury defined as \>2x normal levels for AST or ALT
* Clinical team safety concerns with use of intervention
* Pregnancy
* Prisoners

Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No